Form 4: Natera Co-Founder Jonathan Sheena Reports Stock Transactions
SEC Form 4 Filing
Jonathan Sheena, co-founder of Natera, Inc., reports the acquisition and disposition of common stock and restricted stock units.
Summary
- On March 27, 2024, Jonathan Sheena acquired 447 shares of Natera common stock through the vesting of restricted stock units.
- Sheena also disposed of shares of common stock on March 28, 2024, through multiple sales at prices around $90.13 to $90.4158 per share.
- These sales were conducted to cover tax obligations related to the vesting of RSUs and under pre-arranged Rule 10b5-1 trading plans.
- Following these transactions, Sheena directly owns 347,731 shares of Natera common stock and indirectly owns 69,582 shares through the Caraluna 1 Trust and 69,582 shares through the Caraluna 2 Trust.
- The RSUs vest over four years, with 25% vesting on March 27, 2021, and the remaining shares vesting in 12 equal quarterly installments thereafter.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence for publicly traded companies. It provides transparency to investors regarding the buying and selling activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small volume of shares involved.
- The sales to cover tax obligations are a normal part of executive compensation and are unlikely to significantly affect stakeholders.
Key Dates
| Date | Description |
|---|---|
| March 27, 2020 | Date of Reporting Person's Stock Unit Agreement |
| March 27, 2021 | 25% of RSUs vested |
| December 13, 2022 | Date Reporting Person adopted Rule 10b5-1 trading plan |
| March 13, 2023 | Date Reporting Person adopted Rule 10b5-1 trading plan |
| March 27, 2024 | Acquisition of 447 shares through RSU vesting |
| March 28, 2024 | Sales of common stock |
| March 29, 2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.